Stock Research for ANGO

Current Price


Latest Update: 2018-03-16 16:00:00

$ 16.8800
$ 16.8400
$ 16.8600

Featured Broker: TradeStation

Get the due diligence for another stock.


ANGO Stock Chart & Research Data

The ANGO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ANGO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ANGO Due diligence Resources & Stock Charts

The ANGO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ANGO Detailed Price Forecast - CNN Money CNN View ANGO Detailed Summary - Google Finance
Yahoo View ANGO Detailed Summary - Yahoo! Finance Zacks View ANGO Stock Research & Analysis -

Stock Analysis

TradeIdeas View ANGO Trends & Analysis - Trade-Ideas Barrons View ANGO Major Holders - Barrons
NASDAQ View ANGO Call Transcripts - NASDAQ Seeking View ANGO Breaking News & Analysis - Seeking Alpha
Spotlight View ANGO Annual Report - OTC Report View ANGO OTC Short Report -
TradeKing View ANGO Fundamentals - TradeKing Charts View ANGO SEC Filings - Bar Chart
WSJ View Historical Prices for ANGO - The WSJ Morningstar View Performance/Total Return for ANGO - Morningstar
MarketWatch View the Analyst Estimates for ANGO - MarketWatch CNBC View the Earnings History for ANGO - CNBC
StockMarketWatch View the ANGO Earnings - StockMarketWatch MacroAxis View ANGO Buy or Sell Recommendations - MacroAxis
Bullish View the ANGO Bullish Patterns - American Bulls Short Pains View ANGO Short Pain Metrics -

Social Media Mentions

StockTwits View ANGO Stock Mentions - StockTwits PennyStocks View ANGO Stock Mentions - PennyStockTweets
Twitter View ANGO Stock Mentions - Twitter Invest Hub View ANGO Investment Forum News - Investor Hub
Yahoo View ANGO Stock Mentions - Yahoo! Message Board Seeking Alpha View ANGO Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ANGO - Insider Cow View Insider Transactions for ANGO - Insider Cow
CNBC View ANGO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ANGO - OTC Markets
Yahoo View Insider Transactions for ANGO - Yahoo! Finance NASDAQ View Institutional Holdings for ANGO - NASDAQ

Stock Charts

FinViz View ANGO Stock Insight & Charts - StockCharts View ANGO Investment Charts -
BarChart View ANGO Stock Overview & Charts - BarChart Trading View View ANGO User Generated Charts - Trading View

Latest Financial News for ANGO

AngioDynamics to Present at the Needham 17th Annual Healthcare Conference
Posted on Thursday March 15, 2018

AngioDynamics, Inc.  , a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that Michael C.

Analysts’ Ratings for Abaxis and Its Peers in February 2018
Posted on Thursday March 01, 2018

Incorporated in California, Abaxis (ABAX) develops, manufactures, and commercializes portable blood analysis systems that are used in a wide range of medical specialties in human or veterinary patient care. The company has worldwide operations and operates in two business segments: the medical market and the veterinary market. Of the ten analysts covering Abaxis in February 2018, two analysts gave the stock “strong buy” ratings, six gave it “hold” ratings, and two gave it “sell” ratings.

A Look at the Performances of Abaxis’s Product Categories
Posted on Thursday March 01, 2018

What's Keeping Abaxis on Investors' Radar in 2018?

AngioDynamics to Report Fiscal 2018 Third Quarter Financial Results on March 29, 2018
Posted on Tuesday February 27, 2018

AngioDynamics, Inc.  , a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, surgery and oncology, today announced that it will report financial results for the third quarter of fiscal year 2018 before the market open on Thursday, March 29, 2018.

Warning: DOMDocument::load( failed to open stream: HTTP request failed! HTTP/1.0 404 Not Found in /home/allsites/ on line 494

Warning: DOMDocument::load(): I/O warning : failed to load external entity "" in /home/allsites/ on line 494

Enter a stock symbol to view the stock details.